2024. SECONDARY PROPHYLAXIS OF VENOUS THROMBOEMBOLISM (VTE) WITH LOW DOSE APIXABAN OR RIVAROXABAN: RESULTS FROM A PATIENT POPULATION WITH MORE THAN 2 YEARS OF MEDIAN FOLLOW-UP. Mediterranean Journal of Hematology and Infectious Diseases. 16, 1 (Feb. 2024), e2024020. DOI:https://doi.org/10.4084/MJHID.2024.020.